Press release content from PR Newswire. The AP news staff was not involved in its creation.
Seelos Therapeutics Announces Issuance of a Patent for Trehalose (SLS-005) in Israel
December 21, 2020 GMT
(PRNewsfoto/Seelos Therapeutics, Inc.)
NEW YORK, Dec. 21, 2020 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has been issued Israeli patent number 241757 by the State of Israel Patent Office titled: “TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE”.
The issued patent covers a method of using trehalose (SLS-005) to treat several neurodegenerative conditions including amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, oculopharyngeal muscular dystrophy (OPMD), Huntington’s disease, spinocerebellar ataxia (SCA), spinal and bulbar muscul
Indorama Ventures educated 13,000 students in 2019 New study shows every 1 baht newswit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswit.com Daily Mail and Mail on Sunday newspapers.
Nordgold to Include Scope 2 Emissions in Future Reporting
London, United Kingdom, 22 December 2020 - Nord Gold SE ( Nordgold or the Company ), the internationally diversified gold producer, today announces that it has awarded KPMG with a contract to update the Company s methodology for measuring greenhouse gas (GHG) emissions. Nordgold s new approach will encompass both direct and indirect emissions (Scope 1 & Scope 2) in accordance with international ISO 14064-1-2018 and GHG Protocol standards.
Previously, Nordgold reported its direct emissions (Scope 1) in accordance with the methodology adopted by the Russian Ministry of Natural Resources and Environment.
The Company will publish its inaugural TCFD for 2020 using the new carbon intensity assessment. The assessment, expected to completed in early 2021, will also form a part Nordgold s 2020 Sustainable Development Report.
Skanska to build new office building in London, UK, for GBP 180M, about SEK 2 billion
News provided by
Share this article
ÖSTERSUND, Sweden, Dec. 22, 2020 /PRNewswire/
Skanska has signed a contract with British Land PLC to build Blossom Street, London. The contract is worth GBP 180M, about SEK 2 billion, which will be included in the order bookings for Europe in the fourth quarter of 2020.
Skanska will construct about 46,300 square meters of commercial, retail, public realm and residential units, as well as install the mechanical, electrical and public health services for the development.
The building is targeting environmental standards to achieve BREEAM excellent.
26 Bewohner und acht Mitarbeiter in Seniorenheim im vogtländischen Grünbach positiv auf Covid-19 getestet | Freie Presse freiepresse.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freiepresse.de Daily Mail and Mail on Sunday newspapers.